Subscribe to RSS Feed

The Future of the PSA Test and Prostate Cancer Diagnosis

NEW YORK, NY--(Marketwired - Mar 27, 2014) - A recent study finds that use
 of the prostate-specific antigen (PSA) test is on the decline, a trend believed to be the result of recommendations from the United States Preventative Services Task Force (USPSTF) and the American Urological Association (AUA). In 2012 and 2013 respectively, the groups issued recommendations to reduce routine PSA testing based on concerns about the over-screening and overtreatment of prostate cancer.

"Screening fewer men or screening less often has the potential to increase the incidence of late-stage prostate cancer diagnoses," said David B. Samadi, MD, Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital. "Early diagnosis helps avoid some of the risks associated with diagnosing prostate cancer after symptoms appear."

Current AUA guidelines for PSA testing:

  • Men under age 40: PSA screening not recommended
  • Men between the ages of 40 and 54: Routine PSA screening not recommended unless at higher risk based on family history or African American race
  • Men between the ages of 55 and 69: Shared decision-making between provider and patient is recommended; if testing is elected, a 2-year interval is suggested
  • Men over age 70: Routine PSA testing is not recommended unless life expectancy is greater than 10-15 years

The PSA blood test is often the first step in a two-part prostate cancer screening process that also includes the digital rectal exam (DRE). Since the PSA is not prostate-cancer specific, abnormal results are explored further through a prostate biopsy.

In reviewing PSA usage from 2008 to 2012, researchers noted a decline across almost all subgroups of physicians, including internal medicine, family medicine, urology, and hematology/oncology. The most significant drop was seen at an urban teaching hospital among urologists with patients aged 50-59 years. Results were published in The Journal of Urology,

"The AUA panel recommends shared decision-making between provider and patient for this age bracket [55-69], but to see these men drop off the PSA radar is concerning," said Dr. Samadi.

The AUA maintains that PSA testing is valuable for some men, pending a thorough discussion of risk factors and health status with an experienced provider. More specifically, however, they advise against routine testing for most men under age 55 or over age 70. "If we choose to follow the recommendations exactly, we risk misadvising patients. These guidelines may be too limiting for younger men for whom a baseline test is useful and older men for whom screening is still valuable," Dr. Samadi said.

Dr. Samadi and his colleagues at The Prostate Cancer Center at Lenox Hill Hospital in New York work closely with men of all ages to design tailored prostate cancer screening and treatment plans based on the full range of risk factors.

Back to Press Releases

Bookmark Using:
Facebook Twitter LinkedIn Email Yahoo

Share on Facebook

Call to Make an Appointment With Dr. David Samadi:


Click the contact link to learn how Dr. Samadi can help treat your prostate cancer and give you back your quality of life.

* The benefits of robotic surgery cannot be guaranteed as surgery is both patient and procedure specific. Previous surgical results do not guarantee future outcomes.

Martin K., Patchogue, NY

I was diagnosed with prostate cancer in January of 2014. After researching for a surgeon the name Dr. David Samadi kept coming up for his expertise and great results. I got an appointment and went in to see Dr. Samadi and was already convinced (from what I read) that I wanted my prostate removed.

R.K. New Jersey, USA

"I would highly recommend Dr.Samadi to anyone dealing with prostate cancer".

Mario J., USA

Several weeks ago I found myself not waking from a nightmare but waking into one. This was after being diagnosed with cancer. My life was spiraling out of control and reaching the epitome of despair. In a true sense of the word, I was experiencing an existential crisis. At moments I even questioned whether my life was worth going forward.

Elyse & Andrew G.

Dr. Samadi is not only an incredibly insightful and talented surgeon, he is  genuine in both his thoughts and actions.  Throughout our experience which had some challenges, Dr.  Samadi was there and in touch with us every step of the way.